Rosefinch Pharmaceutique Private Limited - Company Profile

It is a pharma private limited company based in Amreli, Gujarat, India, established in 2016.
2016 Amreli, Gujarat, India Active
Last Updated:
Access Report
About Rosefinch Pharmaceutique Private Limited

Rosefinch Pharmaceutique Private Limited, a active private limited company, was established on 22 December 2016 in Amreli, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299GJ2016PTC094820. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹18.42 Cr.

It upholds a compliant status. Employing 41 professional, Its leadership includes Abhishek Chandrakant Rabara (Director), Tejas Ashok Parekh (Director), Milankumar Rashmikant Trivedi (Managing Director). Past directors included Abhishek Chandrakant Rabara, Kshitij Nagdev, Tejas Ashok Parekh. It holds ₹35.85 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No 473 (Old Survey 35/1), Village Malaviya Pipariya, Amreli Ahmedabad Highway, Amreli, Gujarat, 365430.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299GJ2016PTC094820

  • Registration Number

    094820

  • Incorporation Date

    22 December 2016

  • Authorized Capital

    ₹30.00 Cr

  • Paid-Up Capital

    ₹18.42 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 30.00 Cr
  • Paid Up Capital ₹ 18.42 Cr
  • Company Age 9 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 35.85 Cr
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth 28.60%
  • Total Assets **** 88.53%
Company report

Rosefinch Pharmaceutique Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rosefinch Pharmaceutique Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rosefinch Pharmaceutique Private Limited?
Current Directors
Name Designation Appointment Date Status
Abhishek Chandrakant Rabara Director 28 Aug 2022 Current
Tejas Ashok Parekh Director 09 Mar 2025 Current
Milankumar Rashmikant Trivedi Managing Director 22 Dec 2016 Current
Jaydeep Chatrabhuj Raigagla Director 24 May 2024 Current
Aditya Hitendrakumar Bhatt Director 26 Dec 2017 Current
Vijaybhai Arjanbhai Nagecha Director 01 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 26 Dec 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Director 30 Sep 2023 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rosefinch Pharmaceutique.

Rosefinch Pharmaceutique Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 28.6%.

Rosefinch Pharmaceutique revenue growth over time
Rosefinch Pharmaceutique profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 88.53%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 28.60%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rosefinch Pharmaceutique?

In 2023, Rosefinch Pharmaceutique had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹358,525,512.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 35.65 Cr
  • Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
30 Dec 2021 Hdfc Bank Limited ₹2.03 M Open
22 Nov 2021 State Bank Of India ₹35.65 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Rosefinch Pharmaceutique?

Unlock and access historical data on people associated with Rosefinch Pharmaceutique, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rosefinch Pharmaceutique, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rosefinch Pharmaceutique's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rosefinch Pharmaceutique
Recent Activity within the Organization
  • Director Appointment

    Tejas Ashok Parekh was appointed as a Director was appointed as a Director on 09 Mar 2025 & has been associated with this company since 1 year 8 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Rosefinch Pharmaceutique Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Jaydeep Chatrabhuj Raigagla was appointed as a Director was appointed as a Director on 24 May 2024 & has been associated with this company since 1 year 9 months . was documented.

  • Balance Sheet

    Progress on Rosefinch Pharmaceutique Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.

  • Director Appointment

    Progress on Mahesh Labhshankar Purohit was appointed as a Company Secretary was appointed as a Company Secretary on 16 May 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Director Appointment

    Abhishek Chandrakant Rabara was appointed as a Director was appointed as a Director on 28 Aug 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rosefinch Pharmaceutique Private Limited?

The CIN of Rosefinch Pharmaceutique Private Limited is U24299GJ2016PTC094820.

Where is Rosefinch Pharmaceutique Private Limited headquartered?

Rosefinch Pharmaceutique Private Limited is headquartered at Survey No 473 (Old Survey 35/1), Village Malaviya Pipariya, Amreli Ahmedabad Highway, Amreli, Gujarat, 365430.

When was Rosefinch Pharmaceutique Private Limited incorporated?

Rosefinch Pharmaceutique Private Limited was incorporated on 22 December 2016.

Who are the current directors of Rosefinch Pharmaceutique Private Limited?

The current directors of Rosefinch Pharmaceutique Private Limited are

What is the primary industry of Rosefinch Pharmaceutique Private Limited?

The primary industry of Rosefinch Pharmaceutique Private Limited is Pharma.

Is Rosefinch Pharmaceutique Private Limited a listed company?

Rosefinch Pharmaceutique Private Limited is unlisted.

What is the capital structure of Rosefinch Pharmaceutique Private Limited?

The authorized capital of Rosefinch Pharmaceutique Private Limited is ₹30.00 Cr, and the paid-up capital is ₹18.42 Cr.

What is the compliance status of Rosefinch Pharmaceutique Private Limited?

The compliance status of Rosefinch Pharmaceutique Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available